Navigation Links
Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find
Date:11/11/2008

ngineering to create mice in which they could turn off Cdk5 within nerve cells in a specific region of the brain where new neurons are born.

Dr. Eisch found that when Cdk5 is removed from immature nerve stem cells, normal cell division occurs, but the nerve cells never reach maturity. Researchers also removed Cdk5 from neighboring mature nerve cells and discovered that this removal resulted in the production of fewer immature nerve cells.

"The techniques we used have moved us several steps beyond what is usually done in the field," Dr. Eisch said. "We're beginning to assemble a dictionary of what regulates neurogenesis. By understanding what's vital at each stage of development, we hopefully can one day manipulate human nerve cells so that the brain can withstand neurodegenerative diseases such as Alzheimer's."

Dr. Bibb studied the "Mr. Hyde" component of Cdk5. Using a different but equally advanced set of genetic approaches, his team studied the effects of turning Cdk5 to the "dark side" by expressing a shortened form of the Cdk5 activating partner called p25. The group found that when paired with p25 in deep brain structures, Cdk5 had destructive effects on motor coordination and learning in the mice.

Neuropsychiatric illnesses such as schizophrenia, attention deficit hyperactivity disorder and drug addiction involve similar brain pathways as the ones studied and implicated in the "Mr. Hyde" aspect of Cdk5, Dr. Bibb said.

Dr. Bibb also used new technology to reach deeper inside the brain and explore regions beyond those typically examined in conjunction with neurodegenerative diseases. His team used a green fluorescent protein to trace Cdk5's activity in mice, allowing the researchers to examine precisely what was happening in the brain when the Cdk5/p25 pairing was overexpressed.

They found that the overexpression damaged circuitry in the area of the brain that controls movement and reward-based learning. T
'/>"/>

Contact: LaKisha Ladson
lakisha.ladson@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Statin Reduces Heart Attack, Stroke Rates in Patients With Normal Cholesterol but Elevated C-Reactive Protein
2. Omega Protein Reports 17 Cents Per Share Third Quarter Profit
3. Signaling between protein, growth factor is critical for coordinated cell migration
4. Quintet of proteins forms new, early-warning blood test before heart attack strikes
5. Cell Biosciences Introduces First Protein Analysis Kits
6. The Wellness(R) Core(R) Family Continues to Grow With New Higher Protein, Grain-Free Canned Varieties for Cats and Dogs
7. Key Blood Test Protein May Not Cause Heart Disease
8. Elaborate Network Drives When and Where Proteins Are Made
9. NIAID awards contracts to search for protein markers of disease
10. MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein
11. New way to control protein activity could lead to cancer therapies

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find
Protein can nurture or devastate brain cells, depending on its 'friends,' researchers find
(Date:11/29/2009)...begin to form between brain cells almost immediate...dy published this week in Nature . Led by researc...the study involved detailed observations of the re...ng motor learning. , The researchers studied mic...get a seed. They observed rapid growth of structur...
(Date:11/29/2009)...eatment equals a $41,000 pay raise, researchers sa... -- Psychological therapy may be much more effecti...winning a lottery prize, suggests an English study...eople who provided information about their mental ...s from a $1,329 course of therapy was so significa...
(Date:11/29/2009)...l healthcare,s uncertain future and rising costs o...e. Affordable Acupuncture Scottsdale answers the c...9, 2009 -- Affordable Acupuncture, LLC opened in S... met with enthusiasm and gratitude. Its increasing... two things, need and cost. "As far as I&rsq...
(Date:11/28/2009)... consider change after 30-minute psychosocial inte...7 (HealthDay News) -- A program that gets persiste...their dangerous behavior may lead to significant a..., The new study included 184 men and women with ...o were randomly assigned to one of two interventio...
(Date:11/27/2009)... GSI Group Inc. (Pink Sh...on technology products and semiconductor systems, ...any,s shareholders has been scheduled for Friday, ...ing will be announced in due course. As previousl...tice from Stephen Bershad, a holder of greater tha...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2
.... 9 Global multiservice public relations,agency W... panel discussion,titled "Healthcare Communication...Highly Regulated Environment." The presentation wi...eg/events/healthcare-webcast.aspx . , Interest...
...., Feb. 9 VNUS(R) Medical,Technologies, Inc. (Nas...es for,the minimally invasive treatment of venous ...nt at the Roth 21st Annual OC Growth Stock Confere...fficer and Vice,President of Finance and Administr...
...irin Announce Support of National Women,s Heart He...ORRISTOWN, N.J., Feb. 9 Bayer HealthCare LLC, the... support of WomenHeart, the nation,s only educatio...An estimated 44 million American women live with o...
...mulation of clopidogrel, the active ingredient in ... PRUSSIA, Pa., Feb. 9 Prism Pharmaceuticals ann...study of PM103, a novel intravenous formulation of...College of Cardiology (ACC) on March 29-31, 2009. ...
...led as One of the Top Achievements in 50 Years of ...(R) Brand, the original Rh immune globulin product...ing Rh-negative women in the prevention of Hemolyt...rld,s first injectable treatment to prevent the di...
..., Feb. 9 Shopko announced today that it won,first...he Year design,competition for the design of its n...in, early last year. Shopko,s new store design wil...g retail design firm Chute Gerdeman Retail in,conj...
Other Medicine News:Health News:Healthcare Online Regulations to Be Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease 2Health News:Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease 3Health News:Prism Pharmaceuticals' Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology 2Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 2Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 3Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 4Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 5Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 6Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 7Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 8Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 9Health News:New Shopko Store Design Takes Top Honors 2Health News:New Shopko Store Design Takes Top Honors 3
(Date:11/27/2009)..., SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall/ ...ems, Inc. (NYSE: VAR ), a premier supplier of X-...will exhibit its full range of detectors at the RS...9 - December 3, 2009. Varian will also be exhibit...as well as specialized cancer treatment technologi...
(Date:11/26/2009)..., JOHANNESBURG, South Africa, Nov. 26 /PRNewswir...ompany of the Year Award in the Generic Pharmaceut...ica Limited. ,, (Logo: http://www.newscom.com/...ny of the Year Award, the following criteria were ...st key competitors: growth strategy and implementa...
(Date:11/25/2009)..., LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCall/...g provider of advanced diagnostic and specialty ...ay agreements with Roche Diagnostics Corporation f... consumables for the veterinary market. ,, (...22/HESKALOGO ) ,, "Heska and Roche share the sa...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 1Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 2Women with endometriosis need special care during pregnancy to avoid risk of premature birth 9079 1Women with endometriosis need special care during pregnancy to avoid risk of premature birth 9079 2New PICC Mimics Nature 50488 1New PICC Mimics Nature 50488 2
...quarter 2008 -, CAMBRIDGE, Mass., Sept. 18 Mille... announced that the interim,analysis results of th...,patients with newly diagnosed multiple myeloma sh...ednisone (VMP) demonstrated a highly statistically... including time-to-disease,progression, complete r...
...ries (NYSE: FRX ) announced today that single dos...onchodilatory response in 17 patients,with COPD ac...today at the,European Respiratory Society (ERS) An....newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ) ... values - important,measures of lung function - we...
Other Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 2Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 3Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 4Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 5
Machat Corneal Spatula
Koch Phacoemulsification Spatula
Hirschman Iris Lens Spatula
Lane Lasik Spatula
Medicine Products: